Comparing two ways of using saphenous vein grafts in heart bypass surgery
Compares two vein graft setups for coronary artery bypass in adults with coronary artery disease.
Key facts
- Who runs it
- Ho Young Hwang
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG
- Status
- Recruiting
- People taking part
- 290 people, planned
- Started
- 18 Apr 2023
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Y-composite grafting
- Aortocoronary grafting
- Record updated
- 17 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who will have coronary artery bypass surgery using the left internal thoracic artery and a saphenous vein graft.
- Age
- Older than 19 years
- Sex
- All sexes can join.
- Disease stage
- Coronary artery disease needing bypass surgery with the left internal thoracic artery and a saphenous vein graft.
- Earlier treatment
- No earlier bypass surgery; repeat bypass operations are excluded.
Main reasons for not taking part
- Other procedures planned at the same time, such as valve or aorta surgery
- Severe illness that limits life expectancy to below 1 year
- Left internal thoracic artery or saphenous vein not usable
- Ascending aorta not usable for the aortocoronary connection
- Emergency operation, connective tissue disease or repeat bypass surgery
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- A patient who is going to receive coronary artery bypass grafting
- Older than 19 years
- Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
Who cannot take part
- Other concomitant procedures (e.g. valve or aorta surgery) is planned
- Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
- Patients who have connective tissue disease
- Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
- Patients whose ascending aorta is not suitable to aortocoronary anastomosis (e.g. ascending aorta aneurysm, porcelain aorta)
- Emergency operation
- Reoperative coronary artery bypass grafting
Where in South Korea
- Seoul National University HospitalSeoul, South KoreaContact: Ho Young Hwang, MD, PhDTaking people
About the trial
What the trial wants to find out
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG.
Read full original descriptionShow less
In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.
The 2 groups in the trial
- Y-composite graftingTreatment being tested
The saphenous vein is anastomosed to the middle portion of the left internal thoracic artery as Y-composite fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
- Aortocoronary graftingExisting treatment, for comparison
The saphenous vein is anastomosed to the ascending aorta as aortocoronary fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison Between the Saphenous Vein as Y-composite Graft Based on the Left Internal Thoracic Artery Versus Aortocoronary Conduit for Coronary Artery Bypass Grafting: A Prospective Randomized Controlled Trial
- Plain-language title
- Comparing two ways of using saphenous vein grafts in heart bypass surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 September 2026